Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 988M | 847M | 1.0B | 774M |
Cost of revenue | 489M | 445M | 456M | 360M |
Gross profit | 499M | 402M | 574M | 414M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 86M | 155M | 102M | 93M |
Other operating expenses | 53M | 64M | 54M | 51M |
Operating income | 234M | 46M | 294M | 150M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 61M | 63M | 65M | 53M |
Other income expense | 25M | 290M | 2M | 2M |
Pretax income | 198M | 287M | 231M | 99M |
Tax provision | 48M | 45M | 53M | 23M |
Net income | 150M | 242M | 178M | 76M |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 384M | 209M | 447M | 293M |
Net income from continuing op. | 150M | 242M | 178M | 76M |
Minority interests | 1M | -2M | 1M | -1M |
Preferred stock dividends | — | — | — | — |